Adaptive clinical trials
Adaptive clinical trials can reduce time-to-market and cut development costs
Using adaptive design to optimise product development at the programme and portfolio level
This whitepaper provides insight into adopting an adaptive design strategy at the level of the product portfolio. It has been written to help senior R&D decision-makers understand the critical role of adaptive design in portfolio decision-making and in appreciating the value that this approach can bring.
Download the whitepaperAdaptive design for medical devices: The faster path to market
An adaptive design clinical trial can help to create a stronger value proposition for your medical device and give you a competitive edge, by reducing development costs and accelerating time-to-market.
Adaptive design allows for pre-set interim analyses to assess efficacy, treatment effect and other critical data, allowing you to make better, more informed development decisions.
ICON experts have more than a decade of experience in the design, simulation and execution of adaptive design trials. Our operational teams and specialised technologies enable medical device manufacturers to apply the power of adaptive design.
Read the whitepaper
Latest on adaptive trial design
If you would like to receive our adaptive trials email updates, including the latest on adaptive trial design, visit our preference centre and select adaptive design.
Receive adaptive trials email updatesAdaptive trials blogs and media articles
Using Bayesian-based, model-assisted designs to improve dose selection in early phase oncology trials
As oncology therapeutics and early phase design models evolve, sponsors will benefit from working with a partner experienced in innovative adaptive designs for phase 1 and 2 oncology trials.
Blog: An introduction to applications of adaptive design
An adaptive design clinical trial can help to create a stronger value proposition for your product and give you a competitive edge, by reducing development costs and accelerating time-to-market.
Blog: Regulatory agencies encourage use of adaptive designs
Over the past few years, regulators (FDA, EMA & PMDA) have provided guidance on the use of adaptive design for clinical development.
Media article: Adaptive design years later: What have we Learned?
Teams at the forefront of adative design are looking to technological breakthroughs, for example by applying quantum computing to machine learning models to predict clincial trial outcomes. Such initiiatives will redefine how sponsors use data and adaptive design, ushering in a new era of clinical trials.
Media article: Adaptive designs: Smarter development programmes for oncology
The different types of adaptive trial designs that have been deployed in oncology trials to good effect, and discusses how they have changed the development paradigm.
Adaptive trials solutions
ICON offers a range of services to help achieve the best possible adaptive trial. These solutions includes the analysis and review of adaptive trial strategies across a portfolio of development products and the provision of oversight for ongoing adaptive trials.
Adaptive trials services